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Abstract
Pathology must aim at a correct and complete diagnosis for the patient, which is timely, 
useful, and understandable to the physician assistant. However, in daily practice, there 
are multiple possibilities of errors in the pathology laboratory, with several impacts on 
patient care and prognosis. In this chapter, we discuss the different concepts of error and 
diagnostic concordances in pathology, at which point in the diagnostic process the errors 
are more frequent, and propose solutions to minimize the chance of their occurrence.
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1. Introduction
In 1999, the American Institute of Medicine (now the National Academy of Medicine) pub-
lished the paper “To Err is Human: Building a Safer Health System” [1], which broadly 
defines medical error as the inability to complete a planned action or the use of a wrong plan 
to achieve a goal. Sirota summarizes the document and its implications for pathology. In his 
chapter, the author considers that the efforts of professional societies, such as the College of 
American Pathologists (CAP), through the Laboratory Accreditation Program, as well as their 
councils and commissions, determine the quality standards for the practice of pathology. In 
professional training, the academic programs and the American Board of Pathology, with their 
certification mechanism, help to ensure the full competence of the practice of pathology [2].
The year 1989 saw the most famous quality control initiative when the CAP introduced the 
Q-PROBES Program, which defines quality in terms of practices of laboratory medicine 
and anatomic pathology. At the same time, 118 Q-PROBES studies have been conducted in 
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thousands of hospitals and independent laboratories in the USA, other places from North 
America, and abroad to identify and describe various experiences. These studies investigate 
the frequency of errors occurrence: the laboratory participants submit data from the calcula-
tion of the normative rates of errors during the laboratory tests. This exchange of information 
occurs so this knowledge convinces laboratory to abandon practices and behaviors harmful 
in the process of laboratory tests [3].
Some reasons may explain less attention to errors in medical labs when compared to other 
medical errors. The higher variability in error during laboratory testing, difficulties in screen-
ing all errors, and all steps involved in the total testing process (TTP) can help explain these 
facts. Besides that, the TTP is more complex and needs cooperation between several health 
institutions. Surprisingly, physicians and other interested people do not understand full 
aspects about the harmfulness of errors in laboratory medicine. In addition to that, it is unde-
sirable for laboratory professionals to report and disclose data about errors [4].
The errors in pathology laboratory are so common that in a self-administered mailed survey 
with 260 practicing pathologists and 81 academic hospital laboratory medical directors, approx-
imately 95% suggested the involvement of any error and only 48% of that professionals believed 
that current error reporting systems were adequate. Among the factors that might make it less 
likely that they would disclose a serious error to a patient, the most common was the possibil-
ity that the patient would not understand what he or she was being told (n = 84, 49.7%) and the 
physician would not be able to explain the error clearly to the patient (n = 68, 40.2%), accord-
ing to the interviewees’ perception. The majority of participants believed that minor and near 
misses needed to be disclosed to patients (n = 120, 72.3% and 34, 20.1%, respectively) [5].
Troxel stands that an expectation from the society of “zero diagnostic error” and the “zero 
error standard” supported by the US judicial system is unattainable for obvious reasons 
(6). Surgical pathology laboratory process is much more complex than highly mechanized 
processes with minimal human participation, such as clinical laboratory analysis. Meier [6] 
describes the pathology production process in 12 steps. The production process begins with 
the correct identification of the patients’ samples (1), selecting tissue specimens (2), label-
ing and transport (3), and accession (4). The process continues with the description of steps 
involving receipt and sampling of specimens (5), fixing, embedding, and cutting section 
(6), mounting, staining the slides, and labeling them (7), and delivering them to surgical 
pathologists (8). The process continues at the pathologist’s desk—with examining, collating, 
and interpreting slides (9) and examining the possibilities of ancillary tests or other informa-
tion (10), the composition of reports, (11) and finally the receipt and interpretation of the 
report (12). Therefore, the surgical pathology report is a complex task with multiple steps in 
which there is a possibility of error.
Meier et al. [7] proposed a standardized error classification that until then did not exist in 
pathology. We describe four types of errors (defective identification, defective specimen, 
defective interpretation, and defective report), distributed according to the processing step 
in the laboratory. In the pre-analytic phase, they describe defective identification (patient, 
tissue, laterality, anatomic location) and defective specimen (loss of the specimen, errone-
ous in measurement or gross description, floaters, inadequate sampling, and the absence of 
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indication of ancillary studies when necessary). The analytic phase includes errors in clas-
sification, false negative or positives, and in post-analytic phase, and they describe the defec-
tive reports (erroneous or missing nondiagnostic information, error in dictation or typing, 
report delivery and errors related to computer or format, transmission and upload error). 
During the pre-analytic phase, wrong identification can be responsible for 27–38% of the 
errors, and specimens-related errors vary from 4 to 10%. In the analytic phase, diagnoses 
misinterpretation occurs from 23 to 28% of the errors, and in post-analytic phase, the defec-
tive report included from 28 to 48% of the errors. This proposed error taxonomy has shown a 
very good interobserver agreement of 91.4% (k = 0.8780; 95% confidence limit, 0.8416–0.9144) 
when applied to amended reports.
2. Diagnostic errors and concordances in pathology
To discuss the errors in pathology, it is essential to conceptualize their goals. Pathology should 
provide a correct and complete diagnosis, in other words timely, useful, and understandable 
for the attending physician [8]. Since the goals of pathology are multifaceted, it is easy to under-
stand that there are multiple possibilities for error. The result must be accurate, based on gold 
standards, and scientifically validated. But what is the gold standard of pathology? Morphology 
is subjective and affected by the observer’s experience. Cytogenetic studies by in situ or molec-
ular hybridization are not applicable to most diseases routinely found in surgical pathology. 
Therefore, the most appropriate is to determine the accuracy, as a measure of diagnostic ade-
quacy; it suggests that most of the qualified pathologists will agree on a similar diagnosis when 
analyzing the same specimen. A major or unacceptable variation is the one that will have a 
great effect on therapy or prognosis, such as in classifying a benign tumor as a malignant one. A 
smaller, acceptable, or minor variation is the one that has no effect on the treatment that would 
alter the progression of the disease, with no effect on the prognosis, such as in some subclassifi-
cations of benign or malignant tumors. These definitions can be applied to the three pathology 
goals (correct, complete, timely) [8, 9]. The errors can be further divided into errors of accuracy, 
that is, how much of the released diagnosis represents the true pathological process and preci-
sion errors related to concordances among pathologists in the interpretation of a case [9].
Meier et al. [10] divided the errors of pathological reports into four categories: errors of inter-
pretation, identification, the specimen, and related to the report. A study based on this classi-
fication evaluated 73 participating institutions of Q-PROBES with 1688 errors in 360,218 cases 
of surgical pathology, with a ratio of 4.7 errors/1000 cases. Rates were higher in institutions 
with pathology residency programs (8.5 vs. 5.0/1000, p = 0.01) or when a percentage of cases 
were reviewed after release (6.7 vs. 3.8/1000, p = 0.10). Interpretation errors were respon-
sible for 14.6% of the cases, 13.3% were identification errors, 13.7% were related to specimen 
errors, and 58.4% errors were of other modalities. In general, more errors were detected by 
pathologists (47.4%) than by clinicians (22%). Incorrect interpretations and specimen errors 
were detected by pathologists (73.5% and 82.7%, respectively, with p = 0.001), while identifi-
cation errors were more frequently detected by other physicians (44.6%, p = 0.001). The rates 
of identification errors were lower when the reports were reviewed by a second pathologist 
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prior to their release (0.0 vs. 0.6/1000, p < 0.001), and errors related to the specimen were 
less reported when released after an intradepartmental review of more difficult cases (0.0 vs. 
0.4/1000, p = 0.02) [11].
Meier [6] describes why the comparison of discrepancy rates is difficult in six different steps 
between the initial diagnostic event and the review event. The first is the difference in the 
internal and external review. In the internal review, the diagnoses under scrutiny were origi-
nally performed in the laboratory, and pathologists in other practices performed an external 
review. Second, the pre-sign-out review was held before a report was issued. Post-sign-out 
review happened after the report had been released. Third, in conference reviews, several 
experts discussed information about diagnosis, prognosis, and treatment of the patient to 
reach an agreement. Some reviews were nonconference related. Fourth, in review per-
formed by an expert, the exam was conducted by a specialist with extensive experience and 
knowledge in the field. The fifth difference was blinded and nonblinded reviews. In blinded 
revisions, the second pathologist had the same amount of information as the first one, and 
sometimes a blinded reviewer was given less case-specific information. The last difference 
was between focused reviews in which the examiner trained the diagnosis of specific types of 
cases and nonfocused revisions in which the pathologist evaluated a defined fraction of cases 
of various specimens or types of diagnoses.
3. Where is the possibility of error?
Valenstein and Sirota [12] described four classifications of errors:
1. Depending on the scenario in which error occurred, in pre-laboratory errors (identifica-
tion errors external to reference laboratory) and laboratory errors. The second form of this 
classification is the division of errors into pre-analytic, analytic, and post-analytic errors. 
This is the most common classification of errors, based on the time and place of the labora-
tory where they occurred: in the pre-analytical, analytical, and post-analytical phases. This 
division is commonly used in clinical analysis laboratories and, since they are based on 
similar work processes, they may be used to evaluate work in pathology.
2. Consequences for the patient: in this case, the errors are distributed in near misses (or “close 
calls”), when the error is detected before causing harm to the patient. On the other hand, ad-
verse events damage the health of a patient, such as a new biopsy or unnecessary procedure. 
Sentinel event is serious, which may cause permanent disability or death because of errors.
3. Type of error: patient misidentification or specimen misidentification.
4. Cause of error: based on the root cause of identification errors—human factors, environ-
ment, equipment failure, and lastly defective rules, policies, or procedures [12].
In a study to develop a reproducible amendment taxonomy, Meier et al. [13] described a 
classification in four categories: misinterpretations, misidentifications, defective specimens, 
and defective reports.
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1. Misinterpretations: This category is divided into three subtypes that occurred in relation 
to two levels of diagnostic information. In the first subtype, the diagnostic conclusions 
described inaccurate information (false-positives or overcalls). In the second subtype, the 
pathologist failed to recognize or lost accurate information (false-negatives or undercalls). 
Both can occur at primary (such as changes between positive and negative status or be-
tween malignant and benign diagnosis) and secondary levels of diagnosis. The secondary-
level diagnosis refers to when the clinical context or prognostic implications depend on the 
pathologic diagnosis, which occurs in malignant tumors.
The third subtype is misclassifications that occur when the pathologist changes similar di-
agnostic categories, for example, the names of a soft tissue sarcoma, without primary di-
agnostic implications or secondary diagnostic information’s modifying impact (the differ-
ently labeled sarcoma behaved biologically with the same degree of aggressiveness during 
the same treatment).
2. Misidentifications: contained four subtypes—patient identification (lacking or wrong); 
tissue designation (e.g., lung confused with liver); laterality specification; and anatomic 
localization (e.g., skin of head misidentified as skin of hand).
3. Specimen defects included five subtypes: lost specimens, specimens with inadequate sam-
ple volume or size, samples with absent or discrepant measurements, inadequately repre-
sentative sampling, and samples with absent or inappropriate ancillary studies.
4. Report defects: Defects of three subtypes were observed. In the first subtype, missing or 
erroneous non-diagnostic information about practitioners involved in the case, procedure 
or dates in which the specimen was collected, or codes regarding the patient, procedure, or 
diagnosis, and so on. The second subtype may be dictated or typographical errors. Failure 
or aberrations in electronic formats or in the transmission of information in reports was 
considered the third subtype of error.
During the material reception, gross examination, and processing, there are many possibili-
ties of error, from the exchange of samples or labels, absence or excessive cuts in the block, to 
cross-contamination with tissues foreign to the specimen included in the final slide. Cognitive 
errors, such as inadequate or incomplete macroscopic descriptions, inadequate representa-
tion of the lesion or of relevant areas necessary for its characterization, may also occur, and 
although some are beyond the pathologist’s control, the responsibility falls directly on him, 
with very serious damage to the patient [8].
Morelli et al. [14] described critical points in pre-analytical steps in a pathology laboratory of 
a leading hospital in Lombardy, Italy. In this work, 8346 histological cases were reviewed, for 
which 19,774 samples were made and from which 29,956 histologies were prepared. They iden-
tified 132 errors, such as accessioning (6.5%), gross dissecting (28%), processing (1.5%), embed-
ding (4.5%), tissue cutting and slide mounting (23%), coloring, (1.5%), labeling, and releasing 
(35%). Some very common errors were not detected in this work: specimen mismatching and 
sample contamination in gross room; mismatching or loss of specimen in embedding, loss, 
exhaustion, or contamination of specimen; and damage or changes of samples on the slides 
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in cutting and slide mounting. As expected, 98.5% of the errors were due to a lack of attention, 
and the majority had no consequences for the patient (88%). Only 10% of the errors resulted in 
a delayed report to the physician. Overall, 85% of errors were detected during gross dissect-
ing, tissue cutting or slide mounting, labeling, and releasing, and 80% of errors could be due to 
incorrect transcriptions of container identification, on slides, and on labels applied to the slides 
at the time of delivery. The quality of the slides is a prime factor for the correct diagnosis. In 
some cases, problems in the cutting, staining, or assembling of the slides can completely prevent 
an adequate diagnosis (Figures 1 and 2).
A study carried out in Pennsylvania, in a teaching hospital with Pathology residency train-
ing, identified 491 errors. Of these, 88% (n = 432) of errors were found in the pre-analytical 
phase, in terms of the order, identification, collection, transportation, material reception, 
and processing in the laboratory. The authors identified 20% (n = 4) of analytical and 39% 
of (n = 8) post-analytical errors [15], as shown in Table 1, associated with Tosuner [16] 
survey data.
It is important to emphasize that the risk of loss or exchange of the specimen is critical in 
the pre-laboratory stage, from the moment of its collection, registration, gross description, 
and confection of the slide. Morelli et al. [14] described additionally in pre-laboratory phase: 
the presence of extraneous tissue (ET), mistaken specimen, excessive number of containers 
in gross dissecting, the absence of decalcification of the specimen when necessary, loss or 
exhaustion of specimen in tissue cutting, wrong choice for thickness section, error in identifi-
cation of block to be cut, and others.
Some pre-analytical artifacts are caused by improper manipulation during the biopsy procedure. 
Excessive tissue trauma caused by tweezers and other surgical instruments (Figures 3 and 4), 
as well as the excessive use of electrocautery in the surgical margins, provoke artifacts that may 
lead to the need for a new biopsy collection.
Figure 1. The inappropriate cut makes it impossible to evaluate the cellularity of this biopsy (Bone marrow, H&E, 400x).
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Layfield and Anderson [17] evaluated the sample labeling errors in 29,479 cases associated 
with 109,354 blocks and 248,013 slides for 18 months. In identification errors, a sample was 
labeled with the incorrect name or identification number. In the case of samples pertaining to 
identification errors, a specimen was incorrectly identified as to the site of origin at the time 
of collection. The authors identified 75 errors; of which 55 (73%) were related to the patient’s 
name and 18 (24%), to the anatomical site. Most of the mistakes (69%, n = 52) occurred in the 
gross examination room, 19 (25%) in the histology laboratory, and four (6%) were related to the 
pathologist’s errors. From the errors, 73% (n = 55) resulted in slides assigned to noncorrespond-
ing patients. Most of the identification errors occurred in skin, esophagus, kidneys, and colon 
biopsies, reflecting the distribution of types of cases received in surgical pathology, with small 
samples from endoscopy and dermatology.
Bixenstine et al. [18] observed 69 hospitals in 3 months and described identification defects 
in 2.9% of cases (1780/60,501; 95% confidence interval [CI] = 2.0–4.4%), 1.2% of containers 
(1018/81,656, 95% CI = 0.8–2.0%), and 2.3% of requisitions (1417/61,245, 95% CI = 1.2–4.6%). 
In container defects, the authors included missing specimen, container with no identified or 
misplaced label, absence or incorrect numeric patient identifier, absence of specimen type or 
source, and/or incorrect specimen type or source (or laterality). Requisition defects included 
the absence of requisition (or a blank requisition), date, time, name, specimen source/type, 
laterality, and/or numeric identifier (or when this information was wrong).
We routinely observe the widespread use of inadequate containers, too small for the specimen, 
which make it difficult to withdraw. It is recommended that containers can be used to allow 
the material to flow without deformities. Some deformities are caused by the narrow fit of the 
part in the container, which prevents its proper fixation. In addition, the bottle should contain 
10–20 times the volume of the piece in a fixative solution and the specimen.
In the cases of small biopsy, the risk of change in gross pathology is more dangerous. Sometimes 
histology shows evidence of suspicious exogenous tissue sample, such as tumor cells with 
nuclear inclusions similar to arachnoidal cells in an endometrial sample, associated with the 
presence of eosinophilic amorphous material morphologically similar to secretory meningi-
oma. Some techniques can be helpful to identify mixed-up tissue specimens, such as microsat-
ellite PCR techniques and another [19, 20].
Figure 2. The presence of folding in tissue does not allow adequate observation of the morphological characteristics 
(Bone marrow, H&E, 400x).
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Preanalytical phase1,2 : 53.3 [22] to 88% [21]
Deliver and registration of material
Incomplete/error in order
Order does not correspond to specimen
Sample quantity does not correspond to order
Specimen without previous marking/incorrect orientation
Incorrect anatomical site
Incomplete/inaccurate clinical information
No material in sample sent
Inappropriate packaging/fixing conditions
Specimen loss in laboratory
Integrity not preserved
Malfunction of equipment
Freezing error
Register error
Analytical phase: 4 [21] to 42.1% [22]
Quality of the slides
Repetition of coloration
Foreign tissue in the specimen
Incorrect block identification
Interpretation errors
Delayed results
Work environment (e.g., refrigeration failure and other equipment failures)
Postanalytical phase: 5.6 [21] to 8% [22] 
Correlation errors of freezing biopsy with conventional histology
Specimen discarded during routine examination
Patients exchange
Transcription errors
Delayed results
Malfunction of laboratory information systems
1Preanalytical phase include accessioning, gross dissecting, processing, embedding, tissue cutting, mounting, coloring, 
labeling and releasing slides. Some errors outside of laboratory were included in this category for didactics effects, 
such as identification mislabeling, loss of specimen etc., because these errors may occur in or out of laboratory. Besides 
that, some errors (e.g., contamination or loss of specimen) can happen in several steps inside the laboratory, since gross 
dissecting, embedding or tissue cutting until slide mounting.
2Another preanalytical errors describe for Morelli et al. [20] include specimen wrongly accessioned, incorrect numbering 
of the blocks or slides, decalcification not performed or insufficient, error in procedure temperature, specimen badly 
positioned, number was reported incorrectly in block or slide, error in thickness selection and loss or exhaustion of 
specimen in cutting, wrong coloring (manually) or error in the choice of the program (in automatic coloring).
Table 1. Distribution of errors according to the operating process phase and examples.
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In an accessioning, many errors can occur. For example, the use of Roman numerals for labeling 
sample bottles can lead to confusion when the numbers 3 and 4 (III and IV, respectively) cannot 
be distinguished clearly. In other cases, the extravasation of formalin or another fixation solu-
tion can clear the identification in the biopsy bottle. It becomes more critical when there are sev-
eral biopsies of the same patient from different anatomic places. In some cases, only the precise 
information in the request form can make the pathologist think of a possible mix-up of species. 
Besides that, the identification in the laboratory is critical as well. Even when clearly written, 
the numbers for slide identification can lead to confusion, such as when the lower horizontal 
bar of the number 2 on the middle slide is rather short and can be mistaken as number 7 [21].
Figure 3. The excess of crushing at the time of biopsy collection makes it impossible to properly evaluate the cellular 
morphology in this bone marrow (Bone marrow, 100x, H&E).
Figure 4. In contrast, in adequate sampling, it is possible to define the morphology of the cellular activity with perfection 
(Bone marrow, 400x, H&E).
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In gross macroscopic examination, cutting or staining of the slides, contaminants can be a rise, 
often called “floaters” by laboratory staff, and most of the time it is easily recognized as such. 
However, contamination of patient samples by strange tissues of a similar type may represent 
a higher risk for misinterpretation, as in the cases in which malignant tissue fragments are 
found in biopsies from patients without malignancy. Carpenter [22] described that the first 
opportunity for this error occurs during gross examination and dissection and that some speci-
men types that are considered high risk for cross-contamination: esophageal biopsies, endocer-
vical curettage specimens, and lymph nodes biopsied for metastatic malignancy. For example, 
contamination of an esophageal biopsy by a very small fragment of normal tissue from the 
small intestine or colon may lead to a false-positive diagnosis of Barrett’s esophagus or, worse, 
when the contamination occurs by a fragment of atypical or “dysplastic” intestinal epithelium 
that may lead to a false interpretation of Barrett’s esophagus with “dysplasia.” In these cases, 
the productivity of the entire laboratory decreases until the pathologist discovers the source of 
contamination because of the longer evaluation time and the need to deepen the histological 
sections. This risk is foremost in laboratories that specialize in one area of the anatomic pathol-
ogy (e.g., dermatopathology, gastrointestinal pathology, etc.) because most of the specimens 
are of a similar type, making it difficult to recognize the floaters. In a laboratory where prostate 
biopsies are exclusively evaluated, a little fragment of the prostate is less likely to be identified 
as extraneous. To reduce this risk, it is essential that a gross station stay clean and organized.
The tissue floaters can be found in histology water baths and the slide stainers. In a study 
performed by Platt et al. [23], extraneous tissue found in stain bath, ranging in size from two 
to three cells to hundreds of cells, and the principal source of contamination was represented 
for the first sets of xylenes and alcohols. Of 13 water baths examined, only one fragment of 
tissue was identified.
In the largest study of extraneous tissue (ET) in surgical pathology, with data about 275 labo-
ratories included in Q-Probes, the quality program of CAP describes the frequency of ET in 
two steps: a prospective and retrospective slide review. An extraneous tissue rate of 0.6% of 
slides (2074/321757) in the retrospective study and 2.9% of slides (1653/57083) was detected. 
In 0.4 and 0.1% in the prospective and retrospective phase, respectively, the presence of ET 
caused difficulties in the diagnostic conclusion [24].
Deficiencies in pre-laboratory steps can occur as well. In a study with 417 laboratories in the 
College of American Pathologists’ voluntary quality improvement program (Q-Probes) iden-
tification and accessioning deficiencies were found in 60,042 (6%) out of a total 1,004,115 cases 
accessioned (median deficiency rate of 3.4%). Identification of specimen was done incorrectly 
in 9.6, 77% errors in discrepant or missing information, and 3.6% involved specimen han-
dling. Absence or incomplete clinical history or diagnosis on the requisition slip represented 
40% of all deficiencies. A correction was done in 69% of cases involving specimen identifica-
tion errors, 58% of correction was done in specimen handling errors, and 27% of cases with 
discrepant or missing information. Lower rates of deficiencies were identified in laboratories 
with lower numbers (<15,000) of accessioned cases and laboratories with a formal written 
plan for the detection of this type of errors [25].
Analytical errors generally have greater evidence of impact on patient care, with potentially dev-
astating consequences for them and the responsible pathologist. Troxel [26] reviewed records of 
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lawsuits against pathologists for diagnostic negligence at a US insurance company responsible 
for the insurance of 1100 pathologists. The pathology presented a low frequency of complaints 
(8.3% per year) and, however, with a great financial impact, measured by a number of indemni-
ties paid per claim since many claims against pathologists resulted from the lack of diagnosis. 
False-negative and false-positive results for cancer accounted for 63 and 22% of claims, respec-
tively. The highest values were related to diagnostic errors in melanomas (US$757,146; 95% 
false negatives), cervicovaginal cytology (US$686,599; 98% false negatives) and breast cancers 
(US$203,192, with the same proportion of false negatives and positives). Also with respect to 
analytical errors, Genta [27] argued that there are external or “suprahistological” elements that 
interfere with the pathologist’s decision which can be divided into two categories: the evidence-
based ones (such as age, sex, ethnicity, and epidemiology) and the elements that arise from 
emotional perceptions, not rooted in objective evidence, named emotional elements, directly 
related to inter and intra-observer variability. Faced with a colon adenoma with high-grade 
dysplasia, the pathologist may believe that surgeons will interpret the presence of dysplasia as 
a license for an unnecessary surgical resection and feel inclined to omit such information from 
the report. Even the errors of pathologists, when discovered, may modify their decision-making 
behaviors. Biases such as visual anticipation, first impression, and preconceived judgments 
influence the critical decision-making processes [28]; however, to what extent such elements 
may interfere with the pathologist’s diagnostic decision-making is uncertain.
It is known that it is strongly recommended that pathologic diagnosis has the following char-
acteristics: (1) accuracy and precision of report, (2) completeness of report, and (3) timeliness. 
The accuracy is based on scientifically validated gold standards, and it can be difficult since 
most of the diagnoses do not have this pattern in morphological analysis. The pathologic 
diagnosis depended on interpretative and subjective skills. The precision is a measurement 
of variation, and a minimal interobserver variation is a major goal in pathology diagnosis 
[29]. In a review of 344 pathology claims reported to The Doctors Company from 1995 to 
1997, Troxel identified 218 claims related to surgical pathology; of these, 54% represented 
claims in six groups of specimen type or “high-risk” diagnostic areas, which included breast 
biopsy, melanoma, lymphoma, fine-needle aspiration, frozen section, and prostate biopsy. 
False-negative diagnosis of malignancy represented 52% of these claims, and 33% of these 
were false-positive diagnosis [30].
In Pakistan, Ahmad et al. [31] performed a study to describe the frequency and types of 
error in surgical pathology reports. They found errors in 210 cases (0.37%) after analyzing 
297 reports during the study conducted on 57,000 surgical pathology cases in a laboratory 
in Karachi in 2014. These comprised 199 formalin-fixed specimens and 11 frozen sections 
represented as 3.8% of a total of 2170 frozen sections. Of this—11 frozen section errors—10 
were misinterpretations and the most comprised malignant diagnosis in the central nervous 
system. Of the 199 permanent specimens, 99 (49.7%) were misinterpretations, and the most 
common subspecialty/anatomic location was gastrointestinal tract (including liver, pancreas, 
and biliary tract) with 23.2% (n = 23), followed by breast (n = 13, 13.1%), and lungs, pleura, 
and mediastinum (n = 10, 10.1%). Some cases of misinterpretations occur as a failure to per-
form special stains, such as Periodic acid-Schiff stain not done in cases of the nasal polyp with 
fungal hyphae. Other errors occur by inadequate gross macroscopy examination when the 
pathologist did not select appropriate sections for microscopic examination. In these cases, 
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lymph node compromised by cancer, a polyp in the gallbladder, and breast carcinomas are 
not described in the first macroscopic description. These errors delay delivery results because 
they require a new specimen exam.
Delays in the report release may be considered as an error in the post-analytical [15] or ana-
lytical phase [16], and the turn-around time (TAT) should be used as an important quality 
measure in laboratories [32]. It is not uncommon for the pathologist to miss the perception 
that there is a patient waiting for his results; therefore, the cases should not remain for longer 
than necessary on the pathologist’s desk [33]. Delays in TAT may be considered during the 
pre-analysis as delays in reception, gross examination, and material processing; during the 
analysis (in the diagnostic interpretation of the pathologist) or after the analysis, as the delay 
in typing and release of the reports to the patient. In a study performed with 713 cases of surgi-
cal pathology, 551 (77%) were released in 2 days and 162 (23%) in 3 days or more. From these, 
the majority of these cases were found to be pertaining to lungs, gastrointestinal tract, breasts, 
and samples of the genitourinary tract. Diagnosis of malignancy (including staging), consul-
tations with other pathologists, freezing, and immunohistochemical analysis were associated 
with increased TAT in univariate analysis. In the multivariate analysis, the consultation with 
other pathologists, the diagnosis of malignancy, the use of immunohistochemistry, and the 
number of slides evaluated (11.3 when TAT > 2 days and 4.8 when TAT ≤ 2 days) remain as 
significantly associated with increased TAT. Despite CAP recommendation of an analytical 
response time of 2 days or less for most routine cases, the authors conclude that cancer care 
institutions should have a TAT longer than other services [34].
In post-analytical phase, errors include typographical errors, and in some cases, it can lead to 
catastrophic consequences, when the expression “cancer is present” instead of “cancer is not 
present.” Another error in this phase included erroneous or missing non-diagnostic informa-
tion, computer formatting, or transmission [29]. Besides that, some expressions can lead to 
confusing interpretations. It is broadly used in some expressions or phrases to communicate 
varying degrees of diagnostic certainty, for example, “cannot rule out,” “consistent with,” 
“highly suspicious,” “favor,” “indefinite for,” “suggestive of,” and “worrisome for.” Lindley, 
Gillies, and Hassell evaluated 1500 surgical pathology reports and found 35% of these expres-
sions, with wide variation in the percentage of certainty clinicians assigned to the phrases 
studied. The most commonly used phrases were “consistent with” (50%) and “suggestive of” 
(39%). The authors believe that the reasons for use for this expression may include contradic-
tory or low probability staining results, inconsistency in clinical data, uncertain criteria in the 
medical literature, quantity of sample or abnormality, and possibly a concern with medicolegal 
consequences for an over- or under-diagnosis.
Nakhleh and Zarbo describe the amended reports from 359 laboratories, 96% of the 
USA, participants in the 1996 Q-Probes quality improvement program of the College of 
American Pathologists. A total of 3147 amended reports from 1,667,547 surgical pathol-
ogy specimens accessioned in the study. They describe a median of amended reports was 
1.5/1000 cases; of these, 19.2% were issued to correct patient identification errors, 38.7% to 
change the originally issued final diagnosis, 15.6% to change a preliminary written diag-
nosis, and 26.5% to change clinically significant information other than the diagnosis. The 
error detection was most commonly precipitated for a request from a clinician to review 
a case (20.5%) [35].
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4. Looking for solutions
Perkins [36] considers that the disclosure of errors in pathology is complicated by factors 
intrinsic to the specialty. The first barrier, as already mentioned, is the definition of error. 
Another concern is that the patient does not understand the nature of the error or even that 
the clinician is unable to explain it adequately to the patient. Even more complex is the situ-
ation that involves the discovery of the error of another individual: when the pathologist or 
the head of the laboratory discovers an error of a technician/ pathologist in their laboratory 
or external laboratories, or even when the pathologist discovers an error of a clinician from 
the same organization. Therefore, when disclosing an error, the pathologist must consider 
the potential impact on their professional relationships. It is difficult sometimes to define an 
error because there exists a great variability in definitions used in the literature. The most 
commonly utilized is a classification in pre-analytical, analytical, and post-analytical phases, 
but we note that the errors can overlap between these categories. For example, change of 
specimen can occur in pre-analytical and analytical phase. Incorrectly described laterality 
or anatomic sites may occur in any step at the laboratory. Because of that, the comparison of 
studies in literature can be difficult, as the authors used different definitions in their stud-
ies. We described a risk assessment of laboratory errors in surgical pathology in a fishbone 
diagram (Figure 5).
One factor conferred to the increase in the number of medical errors is the excessive decen-
tralization of patient care. Since the patient may have several professionals working in dif-
ferent contexts and none with access to the complete information, the physician would work 
in a situation of greater susceptibility to error [1]. The lack of complete information is criti-
cal in pathology, where many cases depend on correct, clear, and complete clinical informa-
tion for adequate clinical-pathological correlation. In some cases, radiological or laboratory 
 correlation is required. In soft tissue and bone neoplasms, it is important that the pathologist 
Figure 5. Risk assessment using a fishbone diagram.
Errors in Surgical Pathology Laboratory
http://dx.doi.org/10.5772/intechopen.72919
101
is able to interpret radiological exams. The correlation with laboratory data is fundamental for 
interpretation of hepatic biopsies and to define etiology of hepatitis.
In 2016, CAP, the Laboratory Quality Center, and the Association of Directors of Anatomic 
and Surgical Pathology convened a panel of experts to develop a guideline to help define 
the role of case reviews in surgical pathology and cytology. The main recommendations 
cited in the document, with strong agreement among the participants were: (1) pathologists 
should develop procedures for the evaluation of selected cases in order to detect divergences 
and possible interpretation errors, (2) pathologists should conduct case reviews timely to 
prevent negative impacts on patient care, (3) pathologists should have review procedures 
of cases relevant to their practice, as well as continuously monitor and document the results 
of case reviews, and (4) if case reviews show unsatisfactory concordances for a defined case 
type, the pathologists should take action to improve diagnostic compliance. The situation 
may become a little more problematic in places where only one pathologist is responsible 
for all cases; almost all published data refer to situations in which there is a second patholo-
gist responsible for the review. The authors understand that there may be a value addition 
when the pathologist himself revises his cases in the second moment; however, there are 
not enough data in the literature. Each laboratory should develop written procedures and 
record the results of its departmental review studies. According to the authors, the causes 
for low agreement within and among anatomopathological groups are multiple, but two 
factors need to be discussed. Some diagnoses have intrinsically greater variation between 
observers, and these differences should be considered. Furthermore, the histological diag-
nosis is dynamic and different terminologies can be used for the same disease. If a poor 
interobserver agreement is evidenced, methods for improvement should be implemented, 
such as consensus conferences, images for comparison, and so on; however, the quality of 
evidence is very low regarding the best method of improvement. The authors consider that 
best practices may differ according to the characteristics of the disease, individual practices, 
and complementary tests available [37].
Smith and Raab [9] describe how to use the Lean A3 quality control method in surgical pathol-
ogy. Under the Lean method, a management philosophy developed by Toyota Motor Corp., 
pathologists develop activities, that is, examination of slides, diagnostics, and preparation of 
reports from paths through the sequential flow of the sample, with connections, represented 
by the individuals with whom the pathologist communicates. At all stages, there is the pos-
sibility of error, and quality improvements should focus on repairing these failures. The A3 
method is based on defining a problem, analyzing its causes, aiming at an ideal practice, 
and providing an improvement plan [9]. Other authors have also used industrial techniques, 
such as the Six Sigma, with excellent results in error reduction [16, 38]. Examples of their 
measures were as follows: meetings with the clinical teams responsible for delivering the 
material to correct the inadequacy of the samples and intradepartmental meetings, in which 
employees actively participated in the discussions about the errors and their solutions. In 
the pre-analytical phase, the authors established a double-check system of the material, with 
the work divided into successive stages, and at each stage, all specimens were listed and 
checked by two team members, from receipt to material processing, and were subjected to the 
 supervision of a quality control unit [16].
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In a review article by Ellis and Srigley [39], the authors emphasized the importance of struc-
tured and standardized reports for the improvement of diagnostic quality. Standardized 
reports can provide data that contribute to quality improvement programs in health care 
and, when combined with other health data sources, provide important information for 
monitoring, improvement, possible interventions, and benefit analyses in services offered 
to the population. The standardization of reports has proved to be particularly impor-
tant in oncological diagnoses, which can generate much information with epidemiological 
impacts. The International Collaboration on Cancer Reporting maintains the guidelines 
and all the necessary parameters in the histopathological report at http://www.iccr-can-
cer.org/datasets to guide clinical management, as well as to provide prognostic informa-
tion for several cancers; the guidelines panel is a result of a six-week public consultation 
conducted by a Dataset Authoring Committee, with multidisciplinary experts. Lehr and 
Bosman [33], in an article about the communication skills of pathologists, discourage the 
excess of additional notes on artifacts from improper pre-laboratory handling, such as 
incorrect fixation due to electrocautery, and so on. The authors advise that if the problems 
become recurrent, a letter to the material source services with guidelines may help to 
improve the specimens.
Nakhleh et al. [37] state that it is natural to wish to use data from case reviews to measure 
the quality of a pathology laboratory; however, now, it is not clear how best to interpret 
these results, which should not be used to compare the quality between two different labo-
ratories. There are some limitations that may explain such facts: the sources of error, as 
well as their definitions, and the methods used for their measurement, which may differ 
between laboratories. Its clinical impacts may be different. The sensitivity of the evaluation 
method is not controlled and is unknown; in addition, the expected performance points are 
not well defined.
The errors in anatomical pathology have been screened in an internal assessment (review of 
diagnoses, correlation review of cytological and histological diagnoses, or between frozen sec-
tion and permanent diagnoses, clinicopathological conference review of incoming cases, and 
intradepartmental cases or an intradepartmental consultation). The external assessment can be 
done across with regard to participation in quality assurance programs or medicolegal claims. 
Some authors recommended that two pathologists sign-out every cancer diagnosis [40]; how-
ever, this entails greater manpower, a luxury not enjoyed by a few laboratory [29].
Raab et al. [41] performed a nonconcurrent cohort study to compare the effectiveness and 
usefulness of error screening using a targeted 5% random review process (selected by a labo-
ratory information system) and a focused review process. The last was performed in three 
subspecialties: gastrointestinal subspecialty, bone and soft tissue, and genitourinary pathol-
ogy. In this study, pathologists reviewed 7444 cases using a targeted 5% random review pro-
cess and 380 cases using a focused review process and describes 195 (2.6% of reviewed cases) 
and 50 (13.2%) errors detected by the procedures, respectively (p < 0.001). The focused review 
process detected approximately four times much more errors than the targeted 5% random 
review process, despite this last process involving the examination of almost 20 times the 
number of specimens. Major errors detected by the first process was 27 (0.36%) and 12 (3.2%) 
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detected by focused review processes with statistical difference (p < 0.001). The authors con-
cluded that the focused review detects a higher proportion of errors and may be more effec-
tive in strategies for errors screening.
In some cases, the  pathologists consult extradepartmental experts to achieve the better diag-
nostic accuracy, and it is known that the diagnostic criteria vary according to the pathologist’s 
experience. For this reason, it is common to use the same expert for various pathologists. The 
principal limitation of this approach is the high selectivity of the cases because only extraordi-
nary cases must be evaluated by other pathologists, and this does not exclude apparently routine 
cases that must be false-negative [7]. Besides that, the use of expert consultants does not exclude 
the legal responsibility for the first pathologist. In these situations, called “vicarious liability,” 
the first pathologist assumes legal responsibility for having chosen a negligent consultant [30].
5. Conclusions
Errors in Pathology laboratory can result in serious adverse patient outcomes, with cata-
strophic results. False-negative outcomes in oncologic diagnosis result in a dangerous delay 
in adequate treatment. As opposed, to false-positive diagnosis, the patient can be submitted 
to several unnecessary procedures, such as extensive surgical resections, radiation therapy, or 
chemotherapy. It is difficult to imagine in which of the scenes the impact is greater: the delay 
of imperative treatment or an unwanted treatment for a healthy patient. In both situations, the 
consequences can be devastating—adverse effects or mutilations in treatment without clinical 
indications, with possibly fatal consequences, besides medical and legal consequences for the 
pathologist or laboratory involved in the biopsy process, with serious risks to the credibility 
and reputation of the pathologist and the laboratory.
The aim of any pathology laboratory must be establishing procedures that optimize quality 
control, such as additional case reviews and review of their laboratory techniques, to reduce 
interpretive errors or discrepancies in pathology reports. The quality formation, knowledge, 
and experience of the pathologist is crucial for diagnostic accuracy and the greater investment 
of laboratories, greater than higher technologies, must be continuing medical education for 
these professionals.
The taboo around the diagnostic error in pathology should be broken. It is not possible to dis-
cuss the quality controls of laboratories without admitting the possibility of error. Investing 
in continuing medical education, with emphasis on patient safety, as well as on the training 
of new pathologists, with a critical view aimed at reducing errors, is an obligatory path in 
improving the pathology practice.
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